Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Researchers found a way to create cells from stem cells that act like human cells important for hair growth and could be used for hair regeneration treatments.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Combining stem cell-conditioned media with anti-androgen drugs can improve hair growth in male pattern baldness.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Abatacept may help some people with alopecia areata regrow hair.

Parental uveitis causes hair loss in offspring of C57BL/6J mice.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Genetic discoveries are leading to new treatments for alopecia areata.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Genetic factors, including a variant near the FGF5 gene, contribute to hirsutism and are linked to PCOS and metabolic traits.

SQSTM1 gene issues may increase the risk of alopecia areata.

New hair regrowth therapies show promise but need more research.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.